Nuveen Real Asset Income & Growth Fund
summarizeSummary
The filing details a significant transferable subscription rights offering that could increase the fund's outstanding common shares by up to 31.88% if fully subscribed, based on the primary and over-subscription privileges. The estimated subscription price of $12.99 per share is below both the current market price of $13.55 and the net asset value of $13.57 (as of January 21, 2026), indicating a dilutive event for non-participating shareholders. While the fund aims to use the proceeds for new investment opportunities to enhance yields and earnings, the substantial dilution and discounted pricing present a negative signal for existing shareholders who do not fully exercise their rights. A positive aspect is that the offering expenses, estimated at $400,000, will be borne by Nuveen Fund Advisors, not the fund or its common shareholders.
check_boxKey Events
-
Rights Offering Initiated
The fund is offering up to 7,000,000 common shares through transferable subscription rights, with an over-subscription privilege for an additional 1,750,000 shares, totaling up to 8,750,000 shares.
-
Significant Capital Raise
The primary offering aims to raise approximately $90.93 million, representing a substantial capital infusion for the fund.
-
Discounted Pricing
The estimated subscription price of $12.99 per share is below the current market price of $13.55 and the net asset value of $13.57 (as of January 21, 2026).
-
Potential Share Dilution
The offering could increase the number of outstanding shares by up to 31.88%, leading to significant dilution for non-participating shareholders.
auto_awesomeAnalysis
The filing details a significant transferable subscription rights offering that could increase the fund's outstanding common shares by up to 31.88% if fully subscribed, based on the primary and over-subscription privileges. The estimated subscription price of $12.99 per share is below both the current market price of $13.55 and the net asset value of $13.57 (as of January 21, 2026), indicating a dilutive event for non-participating shareholders. While the fund aims to use the proceeds for new investment opportunities to enhance yields and earnings, the substantial dilution and discounted pricing present a negative signal for existing shareholders who do not fully exercise their rights. A positive aspect is that the offering expenses, estimated at $400,000, will be borne by Nuveen Fund Advisors, not the fund or its common shareholders.
この提出時点で、JRIは$13.55で取引されており、市場はNYSE、セクターはUnknown、時価総額は約$3.8億でした。 52週の取引レンジは$10.59から$14.37でした。 この提出書類はネガティブの市場センチメント、重要度スコア8/10と評価されました。